A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects

NCT02571140 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Safety and Bioavailability

Interventions

DRUG: Teriparatide
DRUG: Oral PTH (1-34)

Sponsor

Entera Bio Ltd.